Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
UBS
US Department of Justice
Cantor Fitzgerald
Healthtrust
Johnson and Johnson
Teva
Mallinckrodt

Generated: June 18, 2018

DrugPatentWatch Database Preview

ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Orphenadrine Citrate, Aspirin, And Caffeine patents expire, and what generic alternatives are available?

Orphenadrine Citrate, Aspirin, And Caffeine is a drug marketed by Sandoz and Stevens J and is included in two NDAs.

The generic ingredient in ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE is aspirin; caffeine; orphenadrine citrate. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.

US Patents and Regulatory Information for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074654-001 Dec 31, 1996 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Stevens J ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074988-002 Apr 30, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074654-002 Dec 31, 1996 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Stevens J ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074988-001 Apr 30, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Chinese Patent Office
Chubb
Queensland Health
Federal Trade Commission
Daiichi Sankyo
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.